NOVOSCREEN
Live / Applied — Third extension granted (statement of use) (as of 04 Mar 2026)
What this means for you
Not registered yet, but its 10 Nov 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98265444
- Mark type
- Stylized text
- Filed
- 10 Nov 2023
- Published for opposition
- 30 Jul 2024
- Attorney of record
- Ali Makoui
Goods and services
- Class 005 — Pharmaceuticals: Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, all types of cancer, Alzheimer's disease; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of alcohol, tetrahydrocannabinol (THC); Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic test media in the form of strips and microfluidics devices for measuring levels of cancer biomarkers; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids
- Class 010 — Medical apparatus: Apparatus for blood analysis; Blood testing apparatus; Diagnostic apparatus for the detection of cancer; Immunochemical medical diagnostic testing apparatus for detecting and measuring antibody levels; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical device for detecting cancer; Medical diagnostic apparatus for detecting cancer; Medical diagnostic apparatus for testing DNA and RNA samples; Medical diagnostic apparatus for testing cancer biomarker levels, Alzheimer's disease; Medical diagnostic instruments for the analysis of body fluids; Medical specimen collection devices in the nature of tubes, microtubes, capillary tubes, vials, micro vials for the collection of blood, urine, saliva
- Class 044 — Medical, beauty and agricultural services: Antibody testing for medical diagnostic or treatment purposes; Cancer screening services; DNA screening for medical purposes; Health screening services in the field of Alzheimer's disease and all types of cancer; Immunochemical medical diagnostic testing services for detecting and measuring antibody levels; Medical analysis services for the diagnosis of cancer; Medical diagnosis of Alzheimer's disease and all types of cancer; Medical diagnosis and treatment of Alzheimer's disease and all types of cancer; Medical diagnostic testing, monitoring and reporting services; Medical screening; Medical screening services in the field of Alzheimer's disease and all types of cancer; Medical testing for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of Alzheimer's disease and all types of cancer; Virus testing for medical diagnostic or treatment purposes; Providing cancer screening services
Owner
- 2Pi-Sigma Corp., Newport Beach, CA, US
- 2Pi-Sigma Corp., Newport Beach, CA, US
Prosecution history
- 04 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Mar 2026 — SOU EXTENSION 3 GRANTED
- 03 Mar 2026 — SOU EXTENSION 3 FILED
- 03 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Sept 2025 — SOU EXTENSION 2 GRANTED
- 03 Sept 2025 — SOU EXTENSION 2 FILED
- 03 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 12 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Mar 2025 — SOU EXTENSION 1 GRANTED
- 12 Mar 2025 — SOU EXTENSION 1 FILED
- 11 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 24 Sept 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 30 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Jul 2024 — PUBLISHED FOR OPPOSITION